Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zippelius

Showing results (181-190 of 308) with videos related to

Pageof 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseasesM J Pittet, A Zippelius, D E Speiser, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 17, 2015
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activityNarasimha Rao Uda, Volker Seibert, Frank Stenner-Liewen, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockadeMarcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Immuno-Oncology Technology|February 17, 2022
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the <i>iPROFILER</i> platformV H Koelzer, P Herzig, I Zlobec, et al.
Oncoimmunology|January 9, 2018
The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitorsHeinz Läubli, Viktor H Koelzer, Matthias S Matter, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy studyViktor H Koelzer, Sacha I Rothschild, Deborah Zihler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1Maha Ayyoub, Alfred Zippelius, Mikaël J Pittet, et al.
Frontiers in Cell and Developmental Biology|March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in CancerJinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Four functionally distinct populations of human effector-memory CD8+ T lymphocytesPedro Romero, Alfred Zippelius, Isabel Kurth, et al.
Pageof 31

Showing results (181-190 of 308) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseasesM J Pittet, A Zippelius, D E Speiser, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 17, 2015
Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activityNarasimha Rao Uda, Volker Seibert, Frank Stenner-Liewen, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2020
PD-1<sup>+</sup> natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockadeMarcel P Trefny, Monika Kaiser, Michal A Stanczak, et al.
Immuno-Oncology Technology|February 17, 2022
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the <i>iPROFILER</i> platformV H Koelzer, P Herzig, I Zlobec, et al.
Oncoimmunology|January 9, 2018
The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitorsHeinz Läubli, Viktor H Koelzer, Matthias S Matter, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy studyViktor H Koelzer, Sacha I Rothschild, Deborah Zihler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1Maha Ayyoub, Alfred Zippelius, Mikaël J Pittet, et al.
Frontiers in Cell and Developmental Biology|March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in CancerJinyu Wang, Michela Manni, Anne Bärenwaldt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Four functionally distinct populations of human effector-memory CD8+ T lymphocytesPedro Romero, Alfred Zippelius, Isabel Kurth, et al.
Pageof 31